Ruggero Ruggieri

Ospedale Sacro Cuore Don Calabria

Papers

1

Total Citations

45

H-Index

1

About

Dr. Ruggero Ruggieri is a leading figure in radiation oncology, specializing in advanced radiotherapy techniques for prostate cancer. His research focuses on optimizing treatment delivery through volumetric modulated arc therapy (VMAT) and daily image-guided radiotherapy (IGRT), with a particular emphasis on moderate hypofractionation—a method that delivers higher doses per fraction over fewer sessions. His most cited work, a 2017 study on moderate hypofractionated postprostatectomy VMAT-IGRT, demonstrated the feasibility and safety of this approach, reporting low acute toxicity and paving the way for more convenient, effective postoperative care. With over 45 citations, this paper has influenced clinical protocols worldwide, showcasing his ability to translate technical innovation into practical patient benefits. Dr. Ruggieri’s contributions extend beyond this landmark study; he has consistently advanced the precision of cancer treatment, reducing side effects while maintaining tumor control. His work is essential reading for clinicians and researchers seeking to refine radiotherapy for prostate cancer, blending rigorous dosimetric analysis with real-world outcomes.

Research Focus

Key Achievements

1
H-Index
1
Papers
45
Total Citations
45
Avg Citations/Paper
🏆 Most Cited Paper
Moderate Hypofractionated Postprostatectomy Volumetric Modulated Arc Therapy With Daily Image Guidance (VMAT-IGRT): A Mono-institutional Report on Feasibility and Acute Toxicity
45 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Ospedale Sacro Cuore Don Calabria

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago